EGR2 and B-cell chronic lymphocytic leukemia: In addition, our in vitro 3D OTS CLL model and in vivo PDAC model of NK cell exhaustion demonstrate that EGR2 silencing, not only restores the functionality of anergic cells but also enables these NK cells to potentially control solid tumor growth and influence disease outcomes.